lobbying_activities: 821704

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
821704	85f11362-2a3e-4747-add2-d3d633ceafd7	Q3	HOLLAND & KNIGHT LLP	18466	SHIRE PHARMACEUTICALS, INC	2009	third_quarter	HCR	Worked on H.R. 1548, Pathway for Biosimilars Act; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act; seek amendment regarding biologics in rare diseases; supported amendment incorporating these provisions into H.R. 3200, America's Affordable Health Choices Act of 2009 and the Affordable Health Choices Act in the Senate.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2009-10-01T10:35:18-04:00